Pulmonary hypertension is associated with reduced patient survival after kidney transplantation

Transplantation

Volumn 86, Issue 10, 2008, Pages 1384-1388

  Issa, Naim ^a   Krowka, Michael J ^a   Griffin, Matthew D ^a   Hickson, Latonya J ^a   Stegall, Mark D ^a   Cosio, Fernando G ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Kidney transplantation; Prognosis; Pulmonary hypertension; Survival

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE PRESSURE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL; ECHOGRAPHY; HEART RIGHT VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RENAL REPLACEMENT THERAPY; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; SURVIVAL RATE; SURVIVOR; SYSTOLE;

AGED; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RENAL DIALYSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SURVIVORS; SYSTOLE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 58149336933     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318188d640     Document Type: Article

References (23)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
2. Gill JS, Rose C, Pereira BJ, et al. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 2007; 71: 442.
3. Kasiske BL, Vazquez MA, Harmon WE,etal. Recommendations for the outpatient surveillance ofrenal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 11(suppl 15): S1.
4. Rigatto C, Foley RN, Kent GM, et al. Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 2000; 70: 570.
5. Rigatto C, Parfrey P, Foley R, et al. Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 2002; 13: 1084.
6. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3): s112.
7. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343.
8. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886.
9. Yigla M, Abassi Z, Reisner SA, et al. Pulmonary hypertension in hemodialysis patients: An unrecognized threat. Semin Dial 2006; 19: 353.
10. Nakhoul F, Yigla M, Gilman R, et al. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 2005; 20: 1686.
11. Hinderliter AL, Willis PW, Barst RJ, et al. Effects of long-term infusion of prostacyclin (epoprostenol) onechocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. C irculation 1997; 95: 1479.
12. Kim WR, Krowka MJ, Plevak DJ, et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 2000; 6: 453.
13. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 40S.
14. Krowka MJ. Portopulmonary hypertension and the issue of survival. Liver Transpl 2005; 11: 1026.
15. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 2005; 41: 1122.
16. Pepi M, Tamborini G, Galli C, et al. A new formula for echo-Doppler estimation of right ventricular systolic pressure. J Am Soc Echocardiogr 1994; 7: 20.
17. Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology 2006; 44: 1502.
18. Abassi Z, Nakhoul F, Khankin E, et al. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: Pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens 2006; 15: 353.
19. Yigla M, Nakhoul F, Sabag A, et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123: 1577.
20. Zoccali C, Mallamaci F, Tripepi G. Sleep apnea in renal patients. J Am Soc Nephrol 2001; 12: 2854.
21. Harnett JD, Foley RN, Kent GM, et al. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884.
22. Cosio FG, Alamir A, Yim S, et al. Patient survival after renal transplantation: I.The impactofdialysis pre-transplant.Kidney Int 1998; 53: 767.
23. Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: Implications for liver transplantation. Clin Chest Med 2005; 26: 587.